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Background: Many studies have examined either electroencephalogram (EEG) frequency 
activity or gray matter volumes (GMV) in various psychoses [including schizophrenia (SZ), 
schizoaffective (SZA), and psychotic bipolar disorder (PBP)]. Prior work demonstrated 
similar EEG and gray matter abnormalities in both SZ and PBP. Integrating EEG and 
GMV and jointly analyzing the combined data fully elucidates the linkage between the 
two and may provide better biomarker- or endophenotype-specificity for a particular 
illness. Joint exploratory investigations of EEG and GMV are scarce in the literature and 
the relationship between the two in psychosis is even less explored. We investigated a 
joint multivariate model to test whether the linear relationship or linkage between awake 
EEG (AEEG) frequency activity and GMV is abnormal across the psychosis dimension 
and if such effects are also present in first-degree relatives.
Methods: We assessed 607 subjects comprising 264 probands [105 SZ, 72 SZA, and 
87 PBP], 233 of their first degree relatives [82 SZ relatives (SZR), 71 SZA relatives (SZAR), 
and 80 PBP relatives (PBPR)], and 110 healthy comparison subjects (HC). All subjects 
underwent structural MRI (sMRI) and EEG scans. Frequency activity and voxel-based 
morphometric GMV were derived from EEG and sMRI data, respectively. Seven AEEG 
frequency and gray matter components were extracted using Joint independent com-
ponent analysis (jICA). The loading coefficients (LC) were examined for group differences 
using analysis of covariance. Further, the LCs were correlated with psychopathology 
scores to identify relationship with clinical symptoms.
results: Joint ICA revealed a single component differentiating SZ from HC (p < 0.006), 
comprising increased posterior alpha activity associated with decreased volume in
inferior parietal lobe, supramarginal, parahippocampal gyrus, middle frontal, inferior tem-
poral gyri, and increased volume of uncus and culmen. No components were aberrant 
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inTrODUcTiOn
Several independent electroencephalogram (EEG) and neu-
roimaging (both functional and structural) studies have been 
conducted in schizophrenia (SZ), schizoaffective (SZA), and 
psychotic bipolar disorder (PBP) (1, 2) with the aim of finding 
shared and specific biomarkers for these disorders. Evidence 
indicates considerable overlap in cognitive, structural, cortical 
oscillatory deficits, functional abnormalities (3, 4), and genetic 
sources (5, 6) across psychotic disorders, but these biomarkers 
have typically each been studied in isolation. Further, while most 
have been shown to be abnormal in relatives of affected patients, 
few studies have compared deficits in relatives of probands with 
different disorders (7, 8). A more comprehensive approach to this 
problem would involve studying multiple disorders and multiple 
biomarkers simultaneously (data-fusion) in both probands and 
their relatives. A data-fusion type approach combines two data 
modalities by capitalizing complementary and unique modality-
specific information (for example, functional and structural) in 
an integrated model that can identify within-subject covarying 
patterns (linkage) across modalities (9). Such a linkage serves 
in identifying disease-specific biomarkers or endophenotypic 
markers to advance gene discovery and provide improved and 
disease-specific treatment (10).
For the past two decades, brain imaging and neurophysiological 
techniques elucidated the complex topography of neural systems 
and cognitive alterations in psychotic illnesses (11, 12). Structural 
magnetic resonance imaging (sMRI) and EEG capture spatial 
and temporal neural information that have characterized spatial 
brain network and neurophysiological abnormalities in mental 
diseases. Previous sMRI studies revealed gray matter volume 
(GMV) abnormalities especially in the frontotemporal regions of 
SZ patients (4, 13, 14). Eyes-closed and eyes-awake (resting-state) 
EEG (AEEG) studies found augmented low frequency activity in 
delta, theta, and alpha bands in SZ and bipolar patients (15–17). 
Functional correlates of oscillatory activity revealed theta oscil-
lations to play an important role in hippocampus and prefrontal 
cortex (18, 19) interactions, while alpha oscillations originating in 
thalamocortical neuronal interactions are associated with default 
mode network (20) and various cortical regions (18, 21–23). 
One prior study reported alterations in cortical thickness related 
to abnormal oscillations in SZ (24); nonetheless, the biological 
changes accompanying the oscillatory abnormalities in psychosis 
are unclear and not well characterized. The data analyzed in the 
current study have previously been examined independently for 
endophenotypes and similarities in neurobiological abnormal-
ity across psychotic disorders (4, 16, 25), but the current study 
integrates a subset of EEG and sMRI data in multivariate analysis 
to examine the joint relationship between the two in psychosis.
Univariate methods that examine data from a single imaging 
modality based on a separate model are indeed useful in helping 
us to understand brain function; however, an ideal alternative is 
to construct a model encompassing two or more imaging modali-
ties in a joint analysis with the potential to identify information, 
which is missed by separate analysis. A whole brain univariate 
correlation of sMRI data with EEG activity in various frequency 
bands is limited in sensitivity due to numerous multiple compari-
son procedures (>200 K voxels and multiple EEG frequencies). 
Despite a generally scarce literature on anatomical abnormalities 
associated with EEG activity in psychosis, a few prior studies 
have identified EEG correlates of brain volumes based on a priori 
regional hypotheses (restricted sets of brain regions) rather than 
whole brain analysis (26, 27). In particular, ventricular enlarge-
ment was related to aberrant alpha activity in SZ patients (27). 
Another study reported no association between alpha rhythm 
and glucose metabolic rate in occipital cortices and thalamic 
regions in SZ (28).
Electroencephalogram oscillatory abnormalities have been 
reported (29, 30) both in low frequency ranges (including delta, 
theta, and alpha) and in high frequency ranges (comprising beta 
and gamma). Increased low frequency activity was found in psy-
chosis (31). Abnormal beta activity was demonstrated in both SZ 
and bipolar disorder patients and their relatives (16, 32, 33). Very 
few studies have examined gamma activity in psychosis, primarily 
due to methodological limitations in combatting high frequency 
noise that overlaps with gamma activity. To our knowledge, only 
two studies (32, 34) have examined resting-state gamma activity. 
One failed to find evidence for gamma abnormalities in either 
SZ patients or their family members (34), while the other study 
including SZ probands and relatives found excessive gamma 
activity in frontotemporal regions (32) suggesting that spectral 
abnormalities serve as indicators of genetic liability (endopehno-
types) for SZ. Finally, increased baseline gamma (35) (in the pre-
stimulus period) in SZ was revealed during auditory steady-state 
stimulation. EEG alpha findings in psychosis have been incon-
clusive (29) with reports of increased (36–39), decreased (40, 41), 
and no (42, 43) alpha abnormalities in psychotic patients, perhaps 
due to methodological variations across these studies. A recent 
BSNIP EEG study displayed increased alpha in both SZ and PBP 
patients (16). Gray matter anomalies in the form of volumetric 
in either PBP or SZA or any relative group. No significant association was identified with 
clinical symptom measures.
conclusion: Our data suggest that a joint EEG and GMV model yielded a biomarker 
specific to SZ, not abnormal in PBP or SZA. Alpha activity was related to both increased 
and decreased volume in different cortical structures. Additionally, the joint model failed 
to identify endophenotypes across psychotic disorders.
Keywords: schizophrenia, schizoaffective, psychotic bipolar, joint independent component analysis, 
endophenotypes, biomarkers, eeg, gray matter
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reduction in temporal (44–46) and parietal lobe regions (47, 48) 
and in cerebellum (49) have been reported in psychosis. Gray 
matter abnormalities in SZA disorder resembled those of SZ (4, 
50). Volumetric findings in bipolar disorder have been variable 
with inconsistencies across several brain regions (51). A detailed 
review of structural MRI anomalies in SZ is presented in Ref. (52).
Within a highly networked brain, it is reasonable to expect 
changes in neuroelectric brain activity in one region, may be 
related to alterations of brain morphometry in different regions. 
Importantly, such a model has the potential to reveal sources 
of EEG alterations in brain regions that have an indirect role in 
the source activity, but may not be a direct generator of the EEG 
activity. Currently, multimodal fusion has been utilized in studies 
to analyze multiple data sets as it gives important decompositions 
and at the same time, reduces the assumptions of the data model. 
Examples include multimodal canonical correlation analysis (53, 
54) and joint independent component analysis (jICA) (55, 56). 
Most multimodal studies focused on combining sMRI with fMRI 
(55); sMRI with evoked event-related potential (57) but to our 
knowledge, no report exists on integrating awake EEG (AEEG) 
and sMRI to examine their coupling in psychosis. The use of EEG, 
which allows one to measure neural activity, together with sMRI, 
to assess the anatomical source of activation that can provide 
meaningful information regarding brain structure-neural oscil-
lation relationship and uncover underlying pathophysiology in 
neuropsychiatric disorders.
The integration of EEG and sMRI can be modeled by multi-
variate jICA, which allows one to simultaneously examine data 
from two or more modalities obtained from the same group of 
subjects by isolating the decomposed factors or source compo-
nents, while permitting a shared mixing parameter (55) between 
the two modalities. This type of cross-information approach 
leverages both EEG and sMRI to enable good temporal and 
spatial resolution. This is especially useful for disorders like SZ 
and bipolar disorder where one can investigate the link between 
structural and functional relationships which would ultimately 
lead to the development of biological markers in the aspects 
of diagnosis and treatment efficacy (58). In the current study, 
we utilize biomarkers derived from AEEG and sMRI in a joint 
model with the primary aim of identifying the linear interac-
tion (association based on additive linear model) between the 
oscillatory activity and GMV disrupted in psychosis through 
empirical multivariate data decomposition. Another goal is to 
verify whether the integrated model provides better efficacy in 
serving as a psychosis specific biomarker or endophenotype or as 
a disease-specific marker yielding better separation from healthy 
comparison (HC) group (compared to separate EEG and GMV 
data models). To our knowledge this is the first study to compare 
joint linear interaction between EEG and gray matter abnor-
malities across psychosis dimension including SZ, SZA and PBP 
probands, and their respective relatives. We sought to identify 
the symptom relationship with the integrated biomarker model 
by correlating with the psychopathology scores. We conducted 
an exploratory study using an empirical data-driven strategy 
to jointly evaluate EEG and whole brain sMRI data to identify 
both neurophysiological and concurrently occurring gray matter 
abnormalities in psychosis.
MaTerials anD MeThODs
Participants
We analyzed data from 607 subjects recruited from the multisite 
Bipolar-Schizophrenia Network for Intermediate Phenotypes 
(B-SNIP) study [interested readers can refer to Ref. (2) for study 
details]. The participants comprised 110 HC subjects, 105 SZ 
probands, 87 PBP, 72 SZA probands, 82 relatives of SZ probands 
(SZR), 80 relatives of PBP probands (PBPR), 71 relatives of SZA 
probands (SZAR). The current sample (N = 607) was selected from 
all participants with both AEEG [from N = 1091 (16)] and sMRI 
(4) data, a subset of B-SNIP cohort comprising N = ~2441 sub-
jects. Groups were not matched on age, gender, and ethnicity. See 
Table 1 for demographic information and clinical characteristics 
for subjects. The BSNIP study protocol was approved by the insti-
tutional review board at Hartford Hospital (Hartford), University 
of Texas Southwestern medical school (Dallas), University of 
Maryland (Baltimore), University of Chicago (Chicago), Wayne 
state university (Detroit), and Harvard University (Boston). All 
participants were explained about the BSNIP study procedure and 
a written informed consent approved by the institutional review 
board at each local site was obtained. Probands were confirmed 
to have a DSM-IV diagnosis of SZ, PBP, and or SZA disorder 
by trained and reliable clinicians using the Structured Clinical 
Interview for DSM-IV (SCID) Axis I Disorders. Probands were 
recruited from inpatient and outpatient settings at the five centers 
(Baltimore, Boston/Detroit, Chicago, Dallas, and Hartford) com-
prising the collaborative B-SNIP study via advertisements, online 
postings, and referral by word of mouth. Non-psychotic relatives 
group included in this sample comprised relatives with psychosis 
spectrum personality disorder (cluster A) and those with no life-
time psychiatric diagnoses (unaffected) and non-psychotic axis I 
(e.g., mood, anxiety) or axis II (cluster B and C disorder) diagnoses. 
Exclusions included presence of neurological illness, substance 
abuse (within 1 month), or dependence (within 6 months) or any 
prior extensive history of drug dependence (DSM-IV). Probands 
were on stable medication doses (see Table 2 for detailed medica-
tion information) for at least 4 weeks and chronic antipsychotic 
treatment for the duration of their illnesses, whereas HCs and 
relatives were free of Axis 1 psychopathology. Also, probands 
were assessed using the Positive and Negative Syndrome Scale 
[PANSS (59)], the Montgomery-Åsberg Depression Rating Scale 
[MADRS (60)], the Young Mania Rating Scale [YMRS (61)], and 
the Schizo-Bipolar Scale [SBS (1)]. Functional status was assessed 
with the Birchwood Functioning Scale (62).
eeg Data acquisition and Processing
EEG data were acquired with an electrode cap fitted with 
66 electrodes, conforming to scalp locations according to 
the International 10–10 system. Instructions were given to 
participants to sit relaxed in a straight-backed chair with eyes 
open and remain still while looking at a fixation cross on a 
monitor. Identical EEG equipment (Neuroscan Compumedics, 
Charlotte, NC, USA) standardized according to the same 
guidelines was used at all the sites. All electrodes were adjusted 
for impedance ≤5 kΩ. Electrooculography (EOG) was used to 
monitor eye movement horizontally with electrodes next to 
TaBle 1 | clinical and demographic information for the study sample.
hc sZ PBP sZa sZr PBPr sZar statistic p Value
Subjects (No.) 110 105 87 72 82 80 71
Mean agea 
(years) (SD)
38.34 (12.36) 33.03 (11.7) 35.51 (13.25) 34.47 (11.35) 44.87 (15.19) 42.66 (14.9) 44.31 (14.74) F6,600 = 11.42 <0.001
Sexb (male/
female)
49/61 72/33 32/55 35/37 29/53 26/54 28/43 χ6
2 35 37= . <<0.0001
Baltimore 17 31 27 16 19 26 16 – –
Bostonc 14 16 12 2 9 7 3 – –
Chicago 16 14 17 9 9 11 5 – –
Dallas 21 8 4 8 3 1 9 – –
Detroitc 6 3 1 0 4 2 3 – –
Hartford 36 33 26 37 38 33 35 –
Group-by-site 
effectsd
– – – – – – – χ24
2 59 84= . <<0.001
Mean epochs 
(SD)
111.26  
(35.12)
115.96  
(35.35)
113.62  
(37.93)
111.07  
(34.57)
107.48  
(30.71)
118.06  
(38.3)
110.39  
(34.41)
F6,600 = 0.87 0.52
Ethnicitye χ24
2 65 97= . <<0.0001
Caucasian 50 46 59 36 48 60 50
African-American 37 47 13 18 22 9 15
Hispanic 11 5 8 12 8 8 3
Asian 5 0 2 0 2 0 1
Mixed 7 7 5 6 2 3 2
CPZf equivalents 484.9 (386.78) 307.9 (269.34) 465.38 (357.7) 203.7 (188.82) 72.9 346.29 (278.2)
PANSS-positive
Range 7–31 7–23 7–32 – – –
Mean (SD) 16.34 (5.46) 11.76 (4.1) 17.24 (5.38) – – –
PANSS-negative
Range 7–33 7–30 7–30 – – –
Mean (SD) 15.4 (5.53) 11.67 (4.06) 15.22 (5.04) – – –
PANSS-general
Mean (SD) 30.64 (8.44) 26.98 (7.26) 33.29 (8.6) – – –
SBS
Mean (SD) 7.88 (1.1) 1.47 (1.29) 5.11 (1.44) – – –
YMRS score
Mean (SD) 5.66 (5.39) 5.13 (5.9) 8.3 (6.68) – – –
MADRS score
Mean (SD) 8.88 (8.08) 10.04 (9.79) 14.94 (10.12) – – –
aSZ probands <HC group.
bDisproportionate number of males in probands and disproportionate number of females in psychotic bipolar probands.
cSince identical EEG equipment was used to collect data at both Boston and Detroit sites, which were managed by the same investigator (two sites were merged in the study). Site 
was used as a factor with five levels in the statistical analysis.
dPatients, relatives, and healthy controls were not uniformly distributed across data collection site.
eRace was not balanced across groups, particularly there were more Caucasians.
fCPZ was available for only one relative of PBP.
CPZ, chlorpromazine; HC, healthy comparison; PANSS, Positive and Negative Syndrome Scale; PBP, psychotic bipolar disorder; PBPR, relatives of psychotic bipolar probands; 
SBS, Schizo-Bipolar Scale; SZ, schizophrenia; SZA, schizoaffective; SZAR, relatives of schizoaffective probands; SZR, relatives of schizophrenia probands.
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both eyes, and vertically with electrodes above and below the 
right eye. EEG signals were digitized at the rate of 1000 Hz with 
0.5 Hz low-frequency and 100 Hz high-frequency filters. Raw 
EEG data were visually inspected to identify bad sensors and 
were fixed by applying a spherical spline interpolation (very 
few subjects’ data were interpolated such that each had no ≥8% 
of bad electrodes); refer to Ref. (16) for the data processing 
details and see Figure 1. Blink artifacts were corrected using 
independent component analysis (63). EEG data were also 
denoised for EKG/EMG artifacts using ICA based artifact 
cleaning methods (64–67). The components were screened 
both visually and using kurtosis and spectral deviation metrics 
for identifying and removing sources of EKG/EMG artifacts. 
Individual EEG trials/epochs were generated by segmenting 
the continuous data into 50% overlapping segments of 2.048 s, 
followed by baseline correction to the mean value of the entire 
trial. Trials containing extreme outliers (exceeding a 150  uV 
threshold), improbable distribution (≥3.25 SD from mean), or 
kurtosis behavior (3.75 SD from mean) or abnormal spectra 
were discarded. Further pruning was done by frequency-
transforming data using a Hamming window and subsequently 
rejecting epochs that were (±) 4 SD from the mean spectral 
TaBle 2 | Talairach coordinates for brain regions associated with alpha 
activity derived from joint independent component analysis.
regions Brodmann L random effects: 
Max Z (x, y, z)
R random effects: 
Max Z (x, y, z)
Positive
Culmen * 4.1 (0, −50, −10) 3.6 (3, −50, −8)
Uncus 28 – 3.7 (19, −6, −25)
negative
Parahippocampal 
gyrus
28, 34 3.26 (−18, −10, 
−18)
4.2 (40, −38, 36)
Supramarginal gyrus 40 3.1 (−36, 17, 21)
Inferior frontal gyrus * 3.99 (−33, 34, −16) 3.1 (33, 33, 3)
Middle frontal gyrus * 3.5 (−36, 26, 29) 3.3 (42, 18, 38)
Superior frontal gyrus * 3.4 (−27, 46, 17) –
Inferior parietal lobule 40 – 3.6 (43, −37, 39)
Inferior temporal 
gyrus
20 3.6 (−56, −26, −20) –
The regions were identified in the gray matter component using a threshold of |Z| ≥ 3.
*denotes Brodmann region not defined.
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amplitude at all frequency points between 0.5 and 50  Hz. 
Finally, EEG data were visually inspected by trained research 
personnel to ensure valid brain EEG patterns were retained for 
subsequent analyses.
structural Magnetic resonance imaging 
acquisition and Voxel-Based Morphometry 
Procedures
All MRI images were collected with 3-T scanners (GE Signa, 
Philips Achieva, Siemens Allegra, and Siemens Trio) as described 
elsewhere (4). High-resolution isotropic T1-weighted MP-RAGE 
sequences (TR = 6.7 ms, TE = 3.1 ms, 8° flip angle, 256 × 240 
matrix size, total scan duration = 10:52.6 min, 170 sagittal slices, 
1 mm slice thickness, 1 mm × 1 mm × 1.2 mm voxel resolution) 
were acquired according to the Alzheimer’s Disease Neuroimaging 
Initiative (ADNI) protocol.1 Foam pads and ear plugs were given 
to minimize head motion and scanner noise.
VBM
Structural MR images were processed using the VBM8 toolbox2 
as implemented in SPM8 with default settings (see Figure 1). The 
following steps were conducted for the T1-weighted MP-RAGE 
images: reorientation, bias-correction, tissue classification, 
spatial normalization to Montral Neurological Image (MNI) 
space followed by high-dimensional non-linear diffeomorphic 
anatomical registration through exponentiated lie algebra 
(DARTEL) normalization that incorporates correction for indi-
vidual brain size (68). The optimally processed and normalized 
gray matter segments were modulated by the amount of warping 
to maintain the total GMV (69) and finally smoothed with an 
8 mm × 8 mm × 8 mm isotropic Gaussian kernel. Voxels within 
a predefined gray matter mask (absolute threshold = 0.3) were 
selected and used for the subsequent jICA.
1 http://adni.loni.usc.edu/
2 http://dbm.neuro.uni-jena.de/vbm
Joint independent component analysis
Typical univariate studies quantify the EEG power and volumes 
in several a priori defined frequency bands and brain regions of 
interest respectively, and evaluate the correlations between the 
two. This approach is limited by the numerous statistical cor-
rections across several frequency bands, numerous EEG leads 
and brain regions of interest to eliminate false positives. In this 
study, we analyzed the whole EEG oscillation spectrum spanning 
(between 1.5 and 50 Hz) from low to high frequency in conjunc-
tion with whole-brain gray matter data. The jICA decomposes 
the data into components that are essentially spectrally filtered 
EEG data covarying with regional volumes (i.e., each component 
represents a spectral activity within a frequency band and linearly 
related regional brain volumes). The EEG and sMRI data were 
analyzed by applying jICA (9, 55) in the fusion ICA Toolbox.3 
jICA is a multivariate statistical approach that extracts hidden 
factors by exploiting the co-variation across two data modalities 
with high dimensionality, while simultaneously maximizing the 
statistical independence in the factors. The loading coefficient 
(LC) of the hidden factors captures the linear linkage between the 
modalities. The linkage parameter and associated hidden source 
components are derived from the data empirically (data-driven). 
One advantage of the multivariate approach is the number of sta-
tistical corrections is limited to the few hidden factors as opposed 
to correcting for all the voxels (>200,000) in a univariate model. 
In simple terms x = AS, where the joint independent sources (S) 
are linearly mixed by a common mixing (loading) parameter (A) 
to achieve the data matrix x = [xEEG, xsmri]. To eliminate bias in the 
joint analysis resulting from the high dimension of the GMV data 
(comprises approximately >200 K voxels), a balanced representa-
tion of the data from both modalities was achieved by interpolat-
ing (upsampling) the EEG frequency activity for each trial and 
averaging the trials to yield the mean frequency amplitude for 
each channel (3178 frequency points/channel between 1.5 and 
50 Hz). The multichannel EEG data was spatially concatenated 
to form a single vector of (1 ×  203392 =  64 ×  3167), which 
in turn was transformed to subject  ×  frequency data matrix 
(xEEG = 607 × 203392). Similarly, the GMV data of each subject 
was converted to a single spatial vector (1 × 202145 voxels) and 
subsequently transformed to form a subject × spatial GMV data 
matrix (xsmri = 607 × 202145). The EEG and GMV data matrices 
were normalized by respective scaling factors such that the sums 
of squares were matched between the two modalities, while main-
taining the relative amplitude of the frequency and GMV data. 
The final data matrix for jICA was obtained by concatenating the 
EEG and GMV (see Figure 1) data matrices [x = (xEEG, xsmri)].
It is not straightforward to estimate the model order for the 
combined EEG and GMV data; hence we adopted a strategy 
employed in prior jICA study (70). An initial estimate of the 
number of independent components was determined using mini-
mum description length (MDL) criteria (71) for EEG and GMV 
data separately. Model order is an estimate (approximate) of the 
low order components that represent the patterns contributing to 
the data. For ICA based studies model order is computed based 
3 http://mialab.mrn.org/software
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on stability criterion (72). ICA is repeatedly applied on the data 
with random initializations and the resulting components are 
grouped into clusters that are assessed by computing a stability 
index [ICASSO (72, 73)]. Using the initial MDL computed model 
order as reference, multiple runs of iICA was evaluated to identify 
stable EEG frequency and gray matter components. With a high 
model order (>10), the EEG frequency components disintegrated 
around the dominant modes. The final model order was selected 
as 7 (with stability index ranging between 0.91 and 0.97) and 
iICA was evaluated using infomax ICA (74). Those components 
for which the LC yielded a significant group main effect were 
examined further. The LC captures the linear aggregate relation-
ship between the EEG frequency activity and GMV measures 
derived from the two modalities. A higher component LC for a 
subject signifies increased contribution to the component. The 
constituents of the EEG frequency and gray matter component 
were identified by converting the component to Z-scores and 
applying a threshold |Z| ≥ 3. The robustness of the component 
was tested by evaluating iICA in leave one subject out sampling 
procedure (N = 607 runs) and computing the Pearson correlation 
between the component obtained in each run and the component 
extracted from the original data.
statistical Data analysis
Joint ICA Analysis
jICA identified 7 EEG–GMV joint components, whose loading 
or mixing parameters were statistically assessed for group differ-
ence. First, all probands (SZ + SZA + PBP) were clustered as a 
group and compared against HC, followed up with a one-way 
analysis of covariance (SPSS v17.0 Statistical Package for the 
Social Science, Chicago, IL, USA) with three between subject fac-
tors (group: SZ, SZA, PBP, SZR, SZAR, PBPR and HC; sex: male/
female; data collection site: five levels). Age and number of EEG 
trials were used as covariates. The p-values for the components 
were adjusted to correct for multiple comparisons (p < 0.05/7). 
Significant main effect was followed up with post  hoc tests to 
assess pair-wise group comparisons adjusted using Bonferroni 
correction. Separate regression (accounting for age, sex, site, and 
FigUre 1 | schematic depicting the processing steps for awake electroencephalogram and gray matter data. The processed EEG spectra 
(concatenated spatially) and voxels data (both data normalized) were concatenated for each subject and Joint Independent component analysis (jICA) was applied 
on the stacked data (vertically concatenated across all K = 607 subjects). N1 = 7 components were derived using jICA. The component whose loading coefficient 
revealed between-group differences was segmented to yield the EEG frequency and linearly associated gray matter component. The dotted line between the 
components indicates linearly paired EEG frequency and gray matter sources obtained from jICA.
FigUre 2 | Mean loading coefficient for the joint electrophysiology-
gray matter component from joint independent component analysis. 
The loading coefficients are plotted for joint component IC5. Analysis of 
covariance identified IC5 to show significant group main effect. Post hoc 
tests with Bonferrroni correction identified the difference was prominent 
between schizophrenia (SZ) probands and healthy comparison (HC) subjects. 
No other proband groups or relatives of probands differed. *indicates 
significance at the p < 0.05 level. The loading coefficients were adjusted for 
discrete factors (sex, site) and covariates (age and number of epochs). Error 
bars represent SD.
November 2015 | Volume 6 | Article 1627
Soh et al. jICA of EEG and Gray Matter in Psychosis
Frontiers in Psychiatry | www.frontiersin.org
number of EEG trials) was carried out to examine the associations 
between the loading parameters of the significant component and 
clinical variables including PANSS, MADRS, YMRS, SBS scores, 
and chlorpromazine equivalents (75) in probands. Additionally, 
medication effect on loading parameters were examined using 
multiple regression by taking into account simultaneous medica-
tion usage, modeled as separate dichotomous discrete variable 
for use or no use of antipsychotics, antidepressants, and mood 
stabilizers. This analysis was restricted to only those probands in 
which the loading parameters characterized abnormality.
resUlTs
Joint eeg–gMV components
Of the seven components derived from these data by jICA (IC1-7 
explaining ~88% of variance), only one component’s loading 
(IC5 with ~16% explained variance) showed significant main 
effect (F1,365 = 9.96, p < 0.0017) in the initial analysis contrasting 
psychosis (SZ + SZA + PBP) vs. HC. IC5 also showed significant 
group (conventional DSM group comparisons) main effect, 
(F6,593 = 2.99, p < 0.006), indicating that the magnitude of linear 
linkage between EEG and GMV in that component was signifi-
cantly different across DSM groups. Post hoc tests revealed that 
the loading for IC5 was significantly higher in SZ probands com-
pared to HC (p < 0.004 after Bonferroni correction for multiple 
group comparisons; see Figure 2), reflecting that strength of the 
coupling between EEG and GMV was increased in SZ compared 
to HC. No other proband groups or their relatives showed differ-
ence vs. HC. The dominant EEG activity and gray matter regions 
representing the component was identified by the applying a 
threshold on the Z-scored component (similar to identifying out-
liers). The EEG feature comprising component IC5 was selected 
with a threshold |Z| ≥ 3 (70, 76) [outliers that are 3 SD (p < 0.01) 
away from the mean], yielding slow alpha activity between 7.4 and 
9.6 Hz and maximal (at Pz) in the posterior channels (Figure 3). 
The EEG frequency component is the waveform at the channel 
location (Pz) where the component was peaking. The associated 
topography was obtained by mapping the peak of each channel 
comprising IC5 in the alpha frequency range (7.5–10 Hz). The 
individual gray matter regions (Figure 4) contributing to IC5 are 
listed in Table 3 with their Talairach coordinates and Z-scores. 
Increased posterior alpha was associated with lesser volume in 
parahippocampal gyrus, inferior temporal gyrus, left middle 
frontal gyrus, right inferior parietal lobule, and greater volume 
in culmen and uncus. Although the threshold used in this study 
is arbitrary, a high threshold results in fewer regions (small sized) 
associated with oscillatory activity, while a low threshold leads 
to false positives. The minimum cluster size for the gray matter 
region was chosen as 20 voxels; however, several of the identified 
regions comprised 53–482 voxels. Thus, we exercise caution on 
the findings as these are sensitive to several parameters including 
the threshold and voxel size. The component IC5 was robust with 
a stability index >0.9 from the leave-one-out analysis.
To evaluate the sensitivity of the jICA approach compared 
to mass univariate approach, we conducted simple regression 
between the maximal gray matter voxel and the peak ampli-
tude of the EEG frequency component. The maximal voxel 
was located in supramarginal gyrus. The peak EEG frequency 
amplitude was at channel Pz at 8.6  Hz (within alpha band). 
The GMV and EEG frequency activity in the original subjects’ 
data at these two maximal locations was correlated (r = −0.16, 
p =  0.000064) in the univariate analysis. This was the maxi-
mum correlation and the associated significance clearly does 
not overcome the threshold for multiple comparisons across 
200 K voxels. Separate ICA was applied on EEG and GMV data 
and the component that best differentiated SZ probands from 
HC in each modality was back-reconstructed using the LCs and 
original data for each group including SZ and HC. The number 
of independent components for EEG and GMV data was 6 
and 12, respectively. The best differentiating (SZ vs. HC) EEG 
component comprised theta activity (5.5–8.3  Hz), maximal at 
Cpz, while the best gray matter component comprised several 
regions including vermis, inferior parietal lobule, thalamus, 
and parts of frontal lobe including left and right inferior frontal 
gyrus. The back-reconstruction procedure was also applied to 
IC5 derived from the joint analysis and the distribution of the 
back-reconstructed component was compared between SZ and 
HC for the joint modality as well as for each modality inde-
pendently using Renyi’s information-theoretic divergence (77) 
criteria. Renyi’s divergence is an inferential statistical distance 
metric that quantifies the difference between the distributions 
of two groups or classes (78). The divergence is evaluated using 
a non-parametric estimator. Greater divergence indicates a 
larger distance between the distribution of SZ and HC group 
back-reconstructed component. The statistic associated with 
Renyi’s divergence was evaluated by re-running (N = 500 runs) 
the group back-reconstruction procedure with shuffled group 
FigUre 4 | gray matter portion of the joint component ic5 obtained from the multivariate joint analysis. The gray matter component was converted to 
Z-scores and the individual brain regions comprising the component were identified with a threshold of |z| ≥ 3 (regions with at least 20 voxels).
FigUre 3 | electrophysiology (eeg) portion of the joint component (ic5) obtained from the multivariate joint analysis. Left: the frequency waveform of 
the component was plotted at the channel location at which the component was peaking. The dotted line indicates the threshold level of |Z| = 3 for identifying the 
constituent of the frequency component. The peak amplitude was within the slow alpha frequency range (7.5–10 Hz). Right: the topography associated with the 
alpha component indicates a posterior distribution. The topography was plotted by mapping the peak in the alpha range for each channel in the EEG portion of the 
joint component. The component was converted to Z-scores.
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labels and estimating the divergence for each run. The p value 
was computed as the ratio of the number of times the divergence 
exceeded the original value to the total number of runs. Thus, 
the p values for the joint model as well as the individual EEG 
and GMV model were p =  0.11, 0.36, and 0.47, respectively. 
Although none of the divergence measures were significant, the 
joint model displayed a trend. The joint model revealed a greater 
divergence (see Figure 5), or separation between the distribu-
tion of the component (IC5) for SZ vs. HC in comparison to the 
distribution contrast for the separate ICA models of EEG and 
GMV, indicating that the SZ abnormality is better differentiated 
by combing both EEG and GMV data.
No significant correlations were found between the load-
ing parameters and PANSS, MADRS, YMRS, SBS scores and 
TaBle 3 | Medication information for study sample.
sZP (n = 105) PBP (n = 87) sZaP (n = 72) sZr (n = 82) PBPr (n = 80) sZar (n = 71) hc (n = 110)
N % N % N % N % N % N % N %
No medication 
taken
5 4.8 5 5.7 3 4.2 66 80.5 53 66.3 53 74.6 107 97.3
Not on 
psychotropic 
medications
8 7.6 23 26.4 10 13.9 80 97.6 78 97.5 2 2.8 0 0
On more than 
one psychotropic 
medications
12 11.4 2 2.3 5 6.9 0 0 0 0 0 0 0 0
Anticholinergic/
antiparkinsonian
19 18.1 6 6.9 9 12.5 0 0 0 0 0 0 0 0
Antidepressant 
(any)
38 36.2 39 44.8 42 58.3 8 9.8 23 28.8 12 16.9 3 2.7
A. Tricyclic 0 0 3 3.4 3 4.2 0 0 2 2 0 0
B. MAO inhibitors 0 0 0 0 0 0 0 0 0 0 0 0 0 0
C. SSRI/SNRI 29 27.6 22 25.3 30 41.6 7 8.5 18 22.5 9 12.7 2 1.8
D. Miscellaneous 15 14.3 23 26.4 22 30.6 1 1.2 5 6.3 2 2.8 2 1.8
Antipsychotic (any) 97 92.4 64 73.6 63 87.5 2 2.4 2 2.5 2 2.8 0 0
A. First generation 21 0.2 5 5.7 12 16.7 0 0 0 0 0 0 0 0
B. Second 
generation
88 83.8 61 70.1 55 76.4 2 2.4 2 2.5 0 0 0 0
Anxiolytic/hypnotic 21 0.2 22 25.3 25 34.7 9 11 7 8.8 5 7 1 0.9
Mood stabilizer (any) 22 21 63 72.4 44 61.1 0 0 3 3.8 5 7 0 0
A. Lithium 7 6.7 25 28.7 12 16.7 0 0 1 1.3 0 0 0 0
B. Anticonvulsants 17 16.2 48 55.2 35 48.6 0 0 2 2.5 5 7 0 0
Miscellaneous, 
centrally active
2 1.9 5 5.7 5 6.9 0 0 0 0 1 1.4 0 0
Stimulants 3 2.9 10 11.4 2 2.8 1 1.2 2 2.5 2 2.8 0 0
HC, healthy comparison; PBP, psychotic bipolar disorder; PBPR, relatives of psychotic bipolar probands; SZ, schizophrenia; SZA, schizoaffective; SZAR, relatives of schizoaffective 
probands; SZR, relatives of schizophrenia probands.
FigUre 5 | Bar graph depicting the divergence score on the individual 
and combined feature space. The feature space includes joint 
electrophysiology (EEG) frequency activity and gray matter volumes (GMV) 
and either of the two separately. Renyi’s divergence compares the distribution 
of the back-reconstructed component between schizophrenia probands and 
healthy comparison groups. The divergence is calculated for the component 
that best separated the two groups for the joint modality (EEG + sMRI) as 
well for each modality. The p values associated with the divergence measure 
for the joint modality as well as the individual EEG and GMV data were 
p = 0.11, 0.36, and 0.45, respectively. The statistic associated with the 
divergence was evaluated by re-running (N = 500) the back-reconstruction 
with shuffled group labels and evaluating the ratio of the number of times the 
divergence measure exceeded the original value to the total number of runs.
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chlorpromazine equivalent dose. Further no association between 
the loading parameters and current use of antipsychotics, antide-
pressants and mood stabilizers were found among SZ probands. 
All the associations were non-significant at p = 0.05.
DiscUssiOn
Numerous brain regions are compromised in the form of func-
tional and structural abnormalities in psychosis (79–81). Prior 
studies have identified regions of gray matter abnormalities 
including the thalamus, cerebellum, temporal lobe and lateral 
frontal regions (4, 52, 82). EEG studies revealed low frequency 
delta, theta, and alpha abnormalities in SZ and PBP probands 
(16, 27, 29, 31, 38). The co-occurring abnormalities in both 
EEG and sMRI in psychosis are unknown and poorly defined. 
Multiple endophenotypes and/or biomarkers have been identi-
fied in psychosis, but it is not clear whether these are related to 
each other or independent; determining this might help clarify 
whether similar or separate biological mechanisms underlie the 
disorder. As a first step, we conducted an exploratory whole-
brain multivariate jICA analysis to demonstrate the biological 
concomitants of oscillatory activity by integrating AEEG fre-
quency activity and GMV from sMRI data across subjects in 
the B-SNIP study and examining their linear relationship that 
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models the shared between-modality relationships in psychosis. 
It should be emphasized that join analysis (joint data fusion) only 
captures components that exhibit a shared relationship between 
the two modalities.
Joint analysis Findings
Brain rhythms encompass wide range of putative functions 
including feature binding and information transfer between 
local and long range brain circuits (83). Similarly, gray matter 
brain regions and circuits serve multiple functions (e.g., cogni-
tive and sensory processes) based on information processing 
governed by neurons, which are also primarily responsible for 
generating brain oscillations. Therefore, it is reasonable to expect 
some relationship between EEG oscillations and variations in 
brain structure. Moreover, generation and regulation of alpha 
oscillations can be linked to brain regions that are direct source 
generators, such as visual occipital cortex (84) or regions that are 
not direct source generators but interact with actual sources. The 
neurobiological mechanisms of brain oscillations are complex. 
We briefly discuss the plausible mechanisms underlying the 
generation of alpha oscillations. Alpha rhythms were initially 
observed in the occipital cortex (85); however, they have also 
been noted in somatosensory cortex (86), auditory cortex (87, 
88), and the prefrontal cortex (89). There remains a consider-
able debate regarding the neural basis of alpha activity; however, 
studies have demonstrated that alpha oscillations are generated 
in neocortex, thalmo-cortical networks (90–92) as well as in 
hippocampus and reticular formation (84), presumably due 
to reciprocal inhibitory and excitatory neuronal interactions 
regulated by gap junctions in inhibitory interneurons (93). 
Generation of awake alpha is associated with the bursting of 
specialized class of high-threshold thamocortical cells at depo-
larized membrane potentials (92). Recent evidence implicates 
muscarinic aceylcholine receptor or metabotropic glutamate 
receptor agonist on thalamic reticular and thalamocortical cells 
during alpha generation (92).
The present study identified slow alpha rhythm including the 
upper end of the theta frequency, whose origin has been associated 
with hippocampal spiking (94) and activation (95, 96), linked to 
memory formation. Prior MRI studies have demonstrated func-
tional relationship between dorsal attention network, posterior 
network involving temporal-occipital regions and default mode 
network comprising superior, medial frontal gyrus and inferior 
parietal lobule (21) with alpha rhythm. Alpha activity was also 
correlated with activations in middle and inferior frontal gyri (22, 
96–98), inferior parietal lobule (99), middle temporal gyrus, and 
cerebellum (20). Source localization analysis of alpha points to 
the role of posterior occipital lobe (100–102) where the visual 
cortical regions are located, extending to subcortical structures 
involving insula, cuneus, and precuneus (100, 103). Glutamate 
and GABAergic (excitatory and inhibitory) neurotransmitters 
play an important role in abnormal brain oscillations in SZ (104). 
Additionally, GMV loss in SZ can be partly attributed to reduced 
neuropil (105, 106), plausibly resulting from NMDA hypo-
function that reduces the excitation of inhibitory GABAergic 
interneurons leading to disinhibition of glutamatergic pyrami-
dal neurons (107). Thus, it is critical to study the relationship 
between alpha activity and structural alterations to understand 
the disease pathology, which is feasible using joint analytic 
techniques. The current findings implicate several brain regions 
directly or indirectly associated (both positively and negatively, 
i.e., anti-correlated) with alpha oscillations. It is plausible that 
these regions are connected via white matter tracts and that this 
plays a joint role in their association with alpha oscillations. For 
example, alpha oscillations generated in the primary visual cortex 
are coordinated and distributed (108) to other regions including 
hippocampus, precuneus, inferior frontal, lingual and parahip-
pocampus gyri, as these regions are connected via white matter 
pathways. Moreover, the white matter tracts (in fronto-temporo-
occipital lobes) (109) assessed using fractional anisotropy (FA) is 
disturbed in SZ (110–112) and such disturbances have functional 
correlates (113). Abnormalities detected using diffusion tensor 
imaging based FA measures are indicative of disturbed organi-
zation/direction of white matter fibers or connections between 
brain regions.
The novel joint analysis reported in this study identified 
a single component, IC5 comprising alpha activity (with 
posterior topography) and gray matter regions including 
parahippocampal gyrus, left inferior temporal gyrus, left mid-
dle frontal gyrus, right supramarginal gyrus, and right inferior 
parietal lobule. This component was abnormal and specific to 
SZ probands, contrary to our hypothesis that EEG–GMV link-
age is psychosis-specific. Also, no first-degree relatives in any 
proband groups exhibited abnormalities compared to HC. Prior 
studies documented both EEG (16) and GMV (4) abnormalities 
in relatives with other non-psychotic axis 1 disorders (mood 
and anxiety) and psychosis spectrum personality disorder (axis 
II), however in the current sample the size of cluster A subjects 
was too small (N = 8) to compare with probands and HC. The 
current findings indicate that the joint model including EEG 
and sMRI capture and characterize a SZ-specific abnormality. 
Additionally, the specificity in differentiating SZ from HC is 
higher (bot not significant) compared to independent investi-
gations of these data. Prior studies have shown certain degree 
of overlap in oscillatory and morphometric abnormalities in a 
direct contrast of both SZ and PBP (4, 16, 25), perhaps reflect-
ing similar biological disturbances in both disorders, however 
our preliminary findings suggest that the linear relationship 
between alpha oscillations and co-occurring volumetric changes 
are unique to SZ and could be used in future investigations for 
elucidating the disease pathology.
alpha Oscillations
Numerous EEG studies have shown SZ patients exhibiting 
abnormal resting neural oscillations across the entire spectrum 
including delta, theta, alpha, beta, and gamma frequency ranges 
(31, 32, 38, 114). SZ probands in the present study revealed 
an augmented alpha oscillatory activity, emphasized over the 
posterior region. Functional correlates of alpha include inhibi-
tion (115), default mode (21, 116), arousal (117), attention, 
and memory processes (84, 118). Prior studies have reported 
conflicting findings on the direction of alpha activity (increases 
or decreases) in SZ probands, perhaps due to the normalization 
of frequency band powers and differences in methodology and 
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sample characteristics such as age and psychotropic medications. 
Our data suggest that morphometric changes in the frontal, pari-
etal, and temporal regions may subserve directly or indirectly as 
a biological substrate for altered EEG alpha activity. There are 
mixed reports of both positive and negative occipital lobe find-
ings in SZ, probably due to different methodology and regions of 
interest definitions that could account for these inconsistencies. 
Another possible explanation is occipital abnormalities in SZ 
may be influenced by sex, although the present study did not 
find diagnostic group-by-sex interactions. Previous studies have 
reported few of the brain regions identified in this study as specific 
sources of EEG alpha activity (96, 100, 119). Further, the current 
findings are partially supported by previous EEG–fMRI studies 
that showed bold activation in middle frontal, inferior temporal 
gyrus, inferior parietal lobule and hippocampus, associated with 
EEG alpha rhythm (20, 21, 23, 96, 98, 99). The direction of the 
alpha-GMV relationship identified in this study is consistent 
with the inverse relationship between alpha and bold activation 
reported in Ref. (23).
sMri regions
Increased posterior alpha was associated with gray matter reduc-
tion in the left inferior temporal gyrus, left middle frontal gyrus, 
right supramarginal gyrus, right inferior parietal lobule and 
parahippocampal gyrus, brain regions previously implicated in 
the pathophysiology of SZ (11, 120–122). The inferior parietal 
lobule, which is a major component of the heteromodal asso-
ciation cortex (123), is crucial in sustaining attention to sensory 
modalities and thus, SZ probands may exhibit impairment of 
sensory integration to a certain degree (123, 124). Similarly, the 
supramarginal gyrus is efficient at integrating incoming sensory 
data and several studies have showed volume reduction in SZ 
(48, 125, 126). The middle frontal gyrus considered to be part 
of the dorsolateral prefrontal cortex, plays an important role in 
working memory known to be compromised in SZ patients (122). 
Additionally, a meta-analysis of 31  voxel-based morphometric 
studies showed reductions of GMV in the left middle frontal 
gyrus (127). Alpha was also associated with larger GMV in cul-
men and uncus regions. This finding is contrary to majority of 
prior reports, except for one study noting greater vermis volume 
in SZ (128). This result indicates that direction of volume changes 
is different in certain regions as opposed to the diffuse reduc-
tions noted in SZ. The primary regions related to alpha in this 
study were mainly associated with sensory and attention process, 
similar to the known functional correlates of alpha, suggesting 
that sensory integration and related processes are disturbed in SZ, 
a hallmark of the disease (129, 130).
Medication effects
Prior reports support the influence of medications, in particular 
antipsychotics on both GMV (131, 132) and EEG oscillatory 
activity (133). Our study did not identify a significant relationship 
between the EEG–GMV linkage and chlorpromazine equiva-
lents. We also tested for simultaneous medication use (modeled 
as binary variable, indicating current use/not using antipsy-
chotic, antidepressants or mood stabilizers) effects on the linear 
EEG–GMV relationship and observed no significant impact. We 
exercise caution on these negative results, as our study probands 
were prescribed multiple medications with varying durations 
and dosages. It is difficult to separate disease from medication 
effects, and this cannot be achieved by only examining probands. 
Although relatives were included in this study, no joint abnormal-
ity was observed in them; thus our ability to rule out medication 
induced effects is less definitive.
advantages and limitations
The strengths of our study encompassed the relatively large 
sample size and the ability to utilize the full array of the EEG 
sensors and entire frequency spectrum (1.5–50 Hz) along with 
high-dimensional sMRI data. The jICA allows one to investigate 
the relationship between EEG and GMV in statistically efficient 
way by decomposing the components on the feature space, and 
examining their shared dependence in patients, compared to the 
mass univariate analysis. The jICA approach assumes a common 
distribution for both EEG and sMRI joint sources across all sub-
jects but with variations in their linear relationship. Limitations 
include unbalanced groups on demographic variables including 
age and sex, whose effects were controlled in the statistical model. 
Despite identifying a SZ-specific biomarker, the data-driven 
approach in the current study failed to reveal dimensional rela-
tionship with psychosis symptom scores, as study patients had 
varying illness chronicity, were in stable phases of illness (restrict-
ing range of symptoms) and were taking numerous medications 
that may affect symptom severity. An alternative approach would 
be to examine first-episode patients with symptoms independent 
of medication influence, although such patients are both rare and 
generally difficult to recruit. The study did not collect detailed 
longitudinal medication histories for probands to completely 
assess possible historical medication influence on the biomarkers. 
We emphasize caution in interpreting the current findings, since 
these were dependent on several parameters including threshold 
and voxel cluster size, which were used in identifying the regions 
and spectral features that were linearly linked in the joint ICA 
component. We were unable to validate the findings reported in 
the present study due to lack of an independent replication sam-
ple; however, the findings were in agreement with those reported 
in several prior studies demonstrating similar regions associated 
with alpha rhythm.
cOnclUsiOn
We conducted an exploratory study using a novel multivariate 
joint analysis for evaluating the linear relationship between AEEG 
frequency activity (between 1.5 and 50 Hz) and their biological 
concomitants in the form of morphometric changes in psychosis. 
Contrary to our initial prediction that linked abnormalities will 
be seen in psychosis (present in all three SZ, SZA, PBP proband 
groups), we identified a single EEG–GMV component comprising 
abnormal alpha activity accompanied by structural abnormalities 
in several brain regions; the abnormal EEG–GMV linear relation-
ship was specific only to SZ probands. These  findings suggest that 
EEG–GMV linkage serve as a potential disease-specific biomarker 
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for SZ, which may be useful in elucidating the pathophysiology of 
SZ. Further, the EEG–GMV linkage was not abnormal in relatives 
of probands. Although the joint model (EEG + GMV) revealed a 
greater divergence compared to the individual models, it was sta-
tistically not significant. The biological and genetic architecture 
underlying the joint oscillatory and imaging abnormality can be 
probed to gain insights into the disease pathology and thereby 
find disease-specific mechanisms that can be investigated for 
treatment options. Future studies will involve integrating func-
tional, task-specific imaging and genetic data with both EEG and 
brain morphometric changes that may aid in the development 
of biological based classification of psychotic illness to provide 
better treatment outcome.
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